These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7665247)

  • 1. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
    Nabeya Y; Loganzo F; Maslak P; Lai L; de Oliveira AR; Schwartz GK; Blundell ML; Altorki NK; Kelsen DP; Albino AP
    Int J Cancer; 1995 Feb; 64(1):37-46. PubMed ID: 7665247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma.
    Sethi N; Kikuchi O; McFarland J; Zhang Y; Chung M; Kafker N; Islam M; Lampson B; Chakraborty A; Kaelin WG; Bass AJ
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
    Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
    Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells.
    Matsubara H; Kimura M; Sugaya M; Koide Y; Gunji Y; Takegana K; Asano T; Ochiai T; Isono K; Sakiyama S; Tagawa M
    Int J Oncol; 1999 Jun; 14(6):1081-5. PubMed ID: 10339661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
    Wang L; Li PF; Geng M; Cao YC; Yin YC
    Diagn Pathol; 2013 Feb; 8():33. PubMed ID: 23432846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum p53 antibody detection on chemosensitivity assay in human colorectal cancer.
    Takeda A; Nakajima K; Shimada H; Imaseki H; Takayama W; Hayashi H; Suzuki T; Ochiai T; Isono K
    J Surg Oncol; 1999 Jun; 71(2):112-6. PubMed ID: 10389868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.
    Zhao R; Quaroni L; Casson AG
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1192-9. PubMed ID: 22980068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma.
    Liu DS; Read M; Cullinane C; Azar WJ; Fennell CM; Montgomery KG; Haupt S; Haupt Y; Wiman KG; Duong CP; Clemons NJ; Phillips WA
    Gut; 2015 Oct; 64(10):1506-16. PubMed ID: 26187504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
    Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
    J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.
    Endo S; Yamato K; Hirai S; Moriwaki T; Fukuda K; Suzuki H; Abei M; Nakagawa I; Hyodo I
    Cancer Sci; 2011 Mar; 102(3):605-13. PubMed ID: 21205074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
    Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
    Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
    Sasaki H; Sheng Y; Kotsuji F; Tsang BK
    Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
    Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
    Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.